Generic Health Pty Ltd v Otsuka Pharmaceutical Co., Ltd [2013] FCAFC 17

Generic Health Pty Ltd v Otsuka Pharmaceutical Co., Ltd [2013] FCAFC 17

The Full Court refused leave to appeal, finding there was no error in the primary judge’s approach or application of legal principle: the evidence supported a prima facie case that the applicant’s supply of the GH Products would likely result in use that infringed claim 7 of the patent, satisfying s 117(2)(b), and that the grant and scope of the interlocutory injunction were justified.

Jurisdiction
Australia
Judgment Date
06 March 2013
Procedural Posture
Application for Leave to Appeal (from Interlocutory Orders in a Patent Infringement Proceeding) / Application for Leave to Appeal From Interlocutory Injunction (full Court of Federal Court)
Outcome
Leave to appeal refused with costs.
Legal Topics
['patents' 'infringement by Supply' 'interlocutory Injunctions' 'construction of S 117 Patents Act' 'cognitive Impairment and Schizophrenia Treatment' 'pharmaceutical Products']
['intellectual Property Law'] ['patents' 'infringement by Supply' 'interlocutory Injunctions' 'construction of S 117 Patents Act' 'cognitive Impairment and Schizophrenia Treatment' 'pharmaceutical Products']

Case Brief

Summary, issues, holding and outcome

More case intelligence is available

Unlock the full research layer for this judgment.

Full judgment text Downloadable case file Legal principles 1 Authorities cited 2 Party arguments 2 Amounts and remedies 1
Sign in to unlock

Procedural Posture

Application for Leave to Appeal (from Interlocutory Orders in a Patent Infringement Proceeding) / Application for Leave to Appeal From Interlocutory Injunction (full Court of Federal Court)

Legal Issues

  1. 1 ['Whether the applicant had reason to believe that its product would be used in an infringing manner within the meaning of s 117(2)(b) of the Patents Act 1990 (Cth)' 'Whether interlocutory injunctive relief was appropriately granted' 'Whether the scope of the injunction exceeded the patentee’s rights' 'Whether the evidence established a prima facie case for infringement']

Ratio Decidendi

The Full Court refused leave to appeal, finding there was no error in the primary judge’s approach or application of legal principle: the evidence supported a prima facie case that the applicant’s supply of the GH Products would likely result in use that infringed claim 7 of the patent, satisfying s 117(2)(b), and that the grant and scope of the interlocutory injunction were justified.

Court Disposition

Leave to appeal refused with costs.

Orders

  • ['Leave to appeal be refused.' "The applicant pay the respondent's costs of the application for leave."]